Actualités, ressources, mises à jour
Une plateforme scientifique pour vous tenir informés de nos dernières recherches et de l'actualité de notre entreprise.
InnoSer présentera de nouvelles données lors du congrès AD/PD 2024, mettant en avant ses capacités de modélisation in vitro des maladies neurodégénératives
We are thrilled to announce that InnoSer, as an innovative preclinical contract research organization (CRO), will be actively participating in the upcoming AD/PD 2024 Conference taking place in Lisbon, Portugal on March 5-9, 2024. The theme of AD/PD 2024 is striving...
Tirer le meilleur parti de l'imagerie bioluminescente pour vos recherches
The application of bioluminescence imaging (BLI) in preclinical research studies offers quantitative, sensitive, longitudinal real-time data and can be applied in: Validation of cancer cell lines, helping to establish improved preclinical cancer mouse models. ...
L'utilisation de l'indice kystique dans le modèle murin de la PKD autosomique dominante
The kidneys of autosomal dominant polycystic kidney disease (ADPKD) patients progressively enlarge due to the formation and expansion of fluid-filled cysts. However, currently there is no available therapy for ADPKD patients that targets the growth of cysts,...
L'importance d'intégrer des mesures translationnelles de la fonction rénale dans vos recherches précliniques : la mesure transdermique du débit de filtration glomérulaire (DFG)
Preclinical Nephrology Research Preclinical studies aiming to assess kidney function in animal models of kidney disease or in response to a test compound have traditionally included readouts such as serum creatinine and blood urea nitrogen (BUN). However, the use of...
Modulateurs de l'eIF2B dans la « matière blanche en voie de disparition »
Vanishing White Matter (VWM) disease is a rare and fatal leukodystrophy, caused by recessive mutations in the five genes encoding the protein complex eukaryotic translation initiation factor 2B (eIF2B). eIF2B plays a crucial role in initiating and regulating the...
Comment s'assurer que l'on travaille avec des modèles de recherche sur les maladies rénales pertinents sur le plan translationnel ?
Although multiple kidney disease models have been described in literature, not all of the models are well-characterized and suitable for preclinical research. To help accelerate the development of new drugs to improve the quality of life of patients living with a...
info@innoserlaboratories.com
Liens rapides